We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CNSY
201
Cerenome
CNSY
$12.4M
$12.4M $1.64 3.14%
INTS icon
202
Intensity Therapeutics
INTS
$12.4M
$12.4M $3.80 7.04%
PASG icon
203
Passage Bio
PASG
$12.4M
$12.4M $3.85 5.64%
BIVI icon
204
BioVie
BIVI
$12.2M
$12.2M $1.40 2.78%
ADIL
205
Adial Pharmaceuticals
ADIL
$11.7M
$11.7M $3.99 0.25%
GDTC icon
206
CytoMed Therapeutics
GDTC
$11.7M
$11.7M $0.9800 5.4%
PHIO icon
207
Phio Pharmaceuticals
PHIO
$11.6M
$11.6M $0.9995 0.51%
KPRX icon
208
Kiora Pharmaceuticals
KPRX
$11.2M
$11.2M $2.53 1.2%
GTBP icon
209
GT Biopharma
GTBP
$11.2M
$11.2M $6.20 2.67%
BLRX
210
BioLineRX
BLRX
$11M
$11M $2.21 3.49%
VTGN icon
211
VistaGen Therapeutics
VTGN
$11M
$11M $0.2471 1.4%
SNTI icon
212
Senti Biosciences Holdings
SNTI
$10.3M
$10.3M $0.3300 2.17%
CALC icon
213
CalciMedica
CALC
$10.1M
$10.1M $1.48 0.67%
CMMB
214
Chemomab Therapeutics
CMMB
$10M
$10M $1.37 2.14%
MTVA
215
MetaVia Inc
MTVA
$9.62M
$9.62M $1.46 1.35%
QNRX
216
Quoin Pharmaceuticals
QNRX
$9.44M
$9.44M $4.70 0.42%
MBRX icon
217
Moleculin Biotech
MBRX
$8.95M
$8.95M $0.4389 1.48%
IMRN
218
Immuron
IMRN
$8.8M
$8.8M $1.09 0.93%
ENSC icon
219
Ensysce Biosciences
ENSC
$8.35M
$8.35M $0.4294 0.09%
CNSP icon
220
CNS Pharmaceuticals
CNSP
$7.94M
$7.94M $5.43 2.45%
FBLG icon
221
FibroBiologics
FBLG
$7.93M
$7.93M $1.14 0.88%
LGVN
222
Longeveron
LGVN
$7.78M
$7.78M $2.44 3.83%
SNGX icon
223
Soligenix
SNGX
$7.69M
$7.69M $0.3535 1.26%
APRE icon
224
Aprea Therapeutics
APRE
$7.62M
$7.62M $0.6050 4.8%
CURX
225
Curanex Pharmaceuticals
CURX
$7.48M
$7.48M $4.77 4.41%
7 8
9
10 11

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 288 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $20.1B.

The largest by market cap are Immuneering (IMRX) at $250M, Nautilus Biotechnolgy (NAUT) at $249M and Vicore Pharma Holding AB ADS (VCRE) at $244M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.